Loading
She heads South Africa's National Cancer Registry and leads its research on cancers linked to HIV, including the national study that links laboratory HIV records to cancer records.
Mazvita Muchengeti is a cancer epidemiologist who oversees cancer surveillance and research at the National Cancer Registry, according to the registry's page, and signs its 2024 Ekurhuleni population-based report as Head of the Department. The registry's page states that she holds a medical degree from the University of Zimbabwe, a Diploma in HIV Management from the College of Medicine of South Africa, a master's degree in epidemiology and biostatistics from the University of the Witwatersrand and a PhD from the University of Bern (2016), whose work explored the spectrum and incidence of HIV-associated cancers in South Africa. She collaborates with IeDEA Southern Africa, the University of Bern and the Swiss Tropical and Public Health Institute on the South African HIV Cancer Match Study, and is senior author of the registry's 2025 analysis of HPV-related cancers.
| Title | Journal | Year |
|---|---|---|
| Changes in incidence of HPV-related cancers in South Africa (2011-21): a cross-sectional analysis of the South African National Cancer Registry Senior author | Lancet Global Health | 2025 |
| Integration of HIV Status in Cancer Surveillance in South Africa: A Call for Action Senior author | Cancer Medicine | 2026 |
| Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study | Clinical Infectious Diseases | 2023 |
| HPV vaccination impact in South Africa: evidence and next steps Comment, with van Schalkwyk C | Lancet Global Health | 2026 |
Many people diagnosed with cancer in South Africa are living with HIV, which affects their treatment, but registry records often do not say so; the authors call on clinicians and pathologists to record HIV status at diagnosis.
Cancers driven by HPV other than cervical cancer are rising quickly in South Africa, most among Black South Africans, which the authors link to high HPV and HIV co-infection; HIV prevention and HPV vaccination are the levers.
As people with HIV in South Africa live longer on treatment, screening and early detection for cancers not caused by infection matter more, while cervical cancer control stays essential.
Shares Integration of HIV Status in Cancer Surveillance in South Africa: A Call for Action, National Health Laboratory Service, South Africa, Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study, National Cancer Registry, South Africa.
Shares National Health Laboratory Service, South Africa, National Cancer Registry, South Africa.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/